Wnt-1 signal induces phosphorylation and degradation of c-Myb protein via TAK1, HIPK2, and NLK.

The c-myb proto-oncogene product (c-Myb) regulates both the proliferation and apoptosis of hematopoietic cells by inducing the transcription of a group of target genes. However, the biologically relevant molecular mechanisms that regulate c-Myb activity remain unclear. Here we report that c-Myb protein is phosphorylated and degraded by Wnt-1 signal via the pathway involving TAK1 (TGF-beta-activated kinase), HIPK2 (homeodomain-interacting protein kinase 2), and NLK (Nemo-like kinase). Wnt-1 signal causes the nuclear entry of TAK1, which then activates HIPK2 and the mitogen-activated protein (MAP) kinase-like kinase NLK. NLK binds directly to c-Myb together with HIPK2, which results in the phosphorylation of c-Myb at multiple sites, followed by its ubiquitination and proteasome-dependent degradation. Furthermore, overexpression of NLK in M1 cells abrogates the ability of c-Myb to maintain the undifferentiated state of these cells. The down-regulation of Myb by Wnt-1 signal may play an important role in a variety of developmental steps.

[1]  C. Mello,et al.  MOM-4, a MAP kinase kinase kinase-related protein, activates WRM-1/LIT-1 kinase to transduce anterior/posterior polarity signals in C. elegans. , 1999, Molecular cell.

[2]  I. Weissman,et al.  A role for Wnt signalling in self-renewal of haematopoietic stem cells , 2003, Nature.

[3]  R. Watson,et al.  Regulation of the Resident Chromosomal Copy of c-myc by c-Myb Is Involved in Myeloid Leukemogenesis , 2000, Molecular and Cellular Biology.

[4]  S. Ishii,et al.  CBP as a transcriptional coactivator of c-Myb. , 1996, Genes & development.

[5]  E. Krebs,et al.  Myb DNA binding inhibited by phosphorylation at a site deleted during oncogenic activation , 1990, Nature.

[6]  S. Ishii,et al.  Myb controls G2/M progression by inducing cyclin B expression in the Drosophila eye imaginal disc , 2002, The EMBO journal.

[7]  Stephen J. Elledge,et al.  The SCFβ-TRCP–ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IκBα and β-catenin and stimulates IκBα ubiquitination in vitro , 1999 .

[8]  C. Eisenberg,et al.  WNT signaling modulates the diversification of hematopoietic cells. , 2000, Blood.

[9]  T. Bender,et al.  c-Myb is essential for early T cell development. , 1999, Genes & development.

[10]  T. Graf,et al.  The v-myb oncogene product binds to and activates the promyelocyte-specific mim-1 gene , 1989, Cell.

[11]  J. Ninomiya-Tsuji,et al.  The kinase TAK1 can activate the NIK-IκB as well as the MAP kinase cascade in the IL-1 signalling pathway , 1999, Nature.

[12]  C. Weston,et al.  The JNK signal transduction pathway. , 2007, Current opinion in genetics & development.

[13]  D. Liebermann,et al.  Deregulated c-myb disrupts interleukin-6- or leukemia inhibitory factor-induced myeloid differentiation prior to c-myc: role in leukemogenesis , 1992, Molecular and cellular biology.

[14]  J. Bishop,et al.  Nucleotide sequence of the retroviral leukemia gene v-myb and its cellular progenitor c-myb: The architecture of a transduced oncogene , 1982, Cell.

[15]  M. Kühl,et al.  An arrow for wingless to take-off. , 2001, BioEssays : news and reviews in molecular, cellular and developmental biology.

[16]  J. Lipsick,et al.  Carboxy-terminal elements of c-Myb negatively regulate transcriptional activation in cis and in trans. , 1992, Genes & development.

[17]  M. Peifer,et al.  Wnt signaling in oncogenesis and embryogenesis--a look outside the nucleus. , 2000, Science.

[18]  J. Bishop,et al.  Drosophila myb is required for the G2/M transition and maintenance of diploidy. , 1998, Genes & development.

[19]  J. Bishop,et al.  Transcriptional activation by the v-myb oncogene and its cellular progenitor, c-myb , 1989, Cell.

[20]  J. Shabanowitz,et al.  Modulation of c-Myb-induced transcription activation by a phosphorylation site near the negative regulatory domain. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[21]  T. Nagase,et al.  Delineation of three functional domains of the transcriptional activator encoded by the c-myb protooncogene. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[22]  R. Eisenman,et al.  Pim-1 kinase and p100 cooperate to enhance c-Myb activity. , 1998, Molecular cell.

[23]  Michael Kühl,et al.  Functional interaction of β-catenin with the transcription factor LEF-1 , 1996, Nature.

[24]  Qinghong Zhang,et al.  Homeodomain Interacting Protein Kinase 2 Promotes Apoptosis by Downregulating the Transcriptional Corepressor CtBP , 2003, Cell.

[25]  A. Leutz,et al.  The Homeobox Gene GBX2 , a Target of the myb Oncogene, Mediates Autocrine Growth and Monocyte Differentiation , 1997, Cell.

[26]  W. Birchmeier,et al.  Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. , 1998, Science.

[27]  S. Ishii,et al.  Increased susceptibility to tumorigenesis of ski-deficient heterozygous mice , 2001, Oncogene.

[28]  T. Gonda,et al.  Expression of myb, myc and fos proto-oncogenes during the differentiation of a murine myeloid leukaemia , 1984, Nature.

[29]  T. Graf,et al.  v-Myb of E26 leukemia virus up-regulates bcl-2 and suppresses apoptosis in myeloid cells. , 1996, Genes & development.

[30]  Christopher J. Thorpe,et al.  MAP kinase and Wnt pathways converge to downregulate an HMG-domain repressor in Caenorhabditis elegans , 1999, Nature.

[31]  Hideyuki Okano,et al.  WRM-1 Activates the LIT-1 Protein Kinase to Transduce Anterior/Posterior Polarity Signals in C. elegans , 1999, Cell.

[32]  A. Bradley,et al.  Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue. , 2003, Cancer cell.

[33]  J. Lipsick,et al.  Oncogenic truncation of the first repeat of c-Myb decreases DNA binding in vitro and in vivo , 1993, Molecular and cellular biology.

[34]  Hans Clevers,et al.  The TAK1–NLK–MAPK-related pathway antagonizes signalling between β-catenin and transcription factor TCF , 1999, Nature.

[35]  Wei Hsu,et al.  The Mouse Fused Locus Encodes Axin, an Inhibitor of the Wnt Signaling Pathway That Regulates Embryonic Axis Formation , 1997, Cell.

[36]  L. Wolff,et al.  Oncogenic activation of c-Myb by carboxyl-terminal truncation leads to decreased proteolysis by the ubiquitin-26S proteasome pathway , 1997, Oncogene.

[37]  G. Mizuguchi,et al.  Transcriptional activation of the c-myc gene by the c-myb and B-myb gene products. , 1992, Oncogene.

[38]  S. Ishii,et al.  Ski is a component of the histone deacetylase complex required for transcriptional repression by Mad and thyroid hormone receptor. , 1999, Genes & development.

[39]  N. Nomura,et al.  DNA binding activity and transcriptional activator function of the human B-myb protein compared with c-MYB. , 1990, The Journal of biological chemistry.

[40]  Walter Birchmeier,et al.  Hot papers in cell biology - J. Behrens, J.P. von Kries, M. Kuehl, L. Bruhn, D. Wedlich, R. Grosschedl, W. Birchmeier: "Functional interaction of beta-catenin with the transcription factor LEF-1" - Comments by Walter Birchmeier , 1999 .

[41]  R. Erikson,et al.  Nlk is a murine protein kinase related to Erk/MAP kinases and localized in the nucleus. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[42]  R. Moon,et al.  The Wnt/Ca2+ pathway: a new vertebrate Wnt signaling pathway takes shape. , 2000, Trends in genetics : TIG.

[43]  Giulia Piaggio,et al.  Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis , 2002, Nature Cell Biology.

[44]  R. Surabhi,et al.  TAK1 is Critical for IκB Kinase-mediated Activation of the NF-κB Pathway , 2003 .

[45]  H. Kwon,et al.  The Homeodomain Protein NK-3 Recruits Groucho and a Histone Deacetylase Complex to Repress Transcription* , 1999, The Journal of Biological Chemistry.

[46]  S. Ishii,et al.  Transformation by carboxyl-deleted Myb reflects increased transactivating capacity and disruption of a negative regulatory domain. , 1991, Oncogene.

[47]  K. Irie,et al.  TAB1: An Activator of the TAK1 MAPKKK in TGF-β Signal Transduction , 1996, Science.

[48]  S. Ishii,et al.  Requirement of the Co-repressor Homeodomain-interacting Protein Kinase 2 for Ski-mediated Inhibition of Bone Morphogenetic Protein-induced Transcriptional Activation* , 2003, Journal of Biological Chemistry.

[49]  R. Nusse,et al.  Mechanisms of Wnt signaling in development. , 1998, Annual review of cell and developmental biology.

[50]  Haruki Nakamura,et al.  Solution structure of a specific DNA complex of the Myb DNA-binding domain with cooperative recognition helices , 1994, Cell.

[51]  G. Struhl,et al.  Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb , 1998, Nature.

[52]  Yoichi Taya,et al.  Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2 , 2002, Nature Cell Biology.

[53]  A. E. Sippel,et al.  Viral myb oncogene encodes a sequence-specific DNA-binding activity , 1988, Nature.

[54]  S. Swerdlow,et al.  A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis , 1991, Cell.

[55]  S. Ishii,et al.  Increase of Solubility of Foreign Proteins in Escherichia coli by Coproduction of the Bacterial Thioredoxin (*) , 1995, The Journal of Biological Chemistry.

[56]  Naoto Ueno,et al.  The TAK1-NLK Mitogen-Activated Protein Kinase Cascade Functions in the Wnt-5a/Ca2+ Pathway To Antagonize Wnt/β-Catenin Signaling , 2003, Molecular and Cellular Biology.

[57]  K. Irie,et al.  Identification of a Member of the MAPKKK Family as a Potential Mediator of TGF-β Signal Transduction , 1995, Science.

[58]  Yongsok Kim,et al.  Homeodomain-interacting Protein Kinases, a Novel Family of Co-repressors for Homeodomain Transcription Factors* , 1998, The Journal of Biological Chemistry.

[59]  A. Sarai,et al.  Recognition of specific DNA sequences by the c-myb protooncogene product: role of three repeat units in the DNA-binding domain. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[60]  A. Sarai,et al.  Transactivation and transformation by Myb are negatively regulated by a leucine-zipper structure. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[61]  K. Weston,et al.  A dominant interfering Myb mutant causes apoptosis in T cells. , 1996, Genes & development.

[62]  J. Ninomiya-Tsuji,et al.  TAK1 Mitogen-activated Protein Kinase Kinase Kinase Is Activated by Autophosphorylation within Its Activation Loop* , 2000, The Journal of Biological Chemistry.